Moore Capital Management, LP Vertex Pharmaceuticals Inc Transaction History

Moore Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $5.8 Million - $6.83 Million	-30,912 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $4.13 Million - $4.81 Million	-19,951 Reduced 39.22%	30,912 $6.64 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $10.5 Million - $14 Million	50,863 New	50,863 $12 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $3.43 Million - $3.89 Million	-25,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $3.7 Million - $4.06 Million	25,000	25,000 $3.8 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.